MULTIPLE-SCLEROSIS - CHANGING TIMES

被引:31
|
作者
KURTZKE, JF [1 ]
机构
[1] VET AFFAIRS MED CTR,NEUROL SERV,WASHINGTON,DC 20422
关键词
MULTIPLE SCLEROSIS; DISTRIBUTION; CHANGING INCIDENCE; EPIDEMICS; TYPE-I EPIDEMIC;
D O I
10.1159/000110240
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Multiple sclerosis (MS) is distributed about the world in three zones of high, medium, and low frequency. All high- and medium-risk areas are among predominantly white populations. Migration studies indicate MS is already acquired by age 15 in high-risk endemic areas and that low-to-high migrants increase their risk from age 11 years. Therefore MS is an environmental disease ordinarily acquired in adolescence with a long incubation before symptom onset. Susceptibility is limited to the period from about age 11 to 47. In general, MS death rates have been declining over time while prevalence rates have increased. Incidence rates have also increased, however, in: northeastern Scotland; Turku, Finland; Hordaland, Norway; Rochester, Minn.; Lower Saxony; several areas of Italy. Incidence was unchanged in northernmost Norway. Conversely, incidence and prevalence rates have decreased in the Shetland-Orkneys; there was a cyclical pattern in incidence in Rostock, GDR; and there was a transient doubling of incidence in Iceland in the post-World War II decade. In the Faroe Islands, MS was absent before 1943 when a major point-source epidemic began, reaching an incidence rate of 10 per 100,000 population in 1945. This was followed by two consecutively smaller epidemics with respective peaks each about 12 years later, and there is now a new epidemic IV on these islands. Explanations for changing incidence of MS over time should bring us closer to solving the etiology of this disease.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] HIDDEN GEOGRAPHIES - THE CHANGING LIFEWORLDS OF WOMEN WITH MULTIPLE-SCLEROSIS
    DYCK, I
    SOCIAL SCIENCE & MEDICINE, 1995, 40 (03) : 307 - 320
  • [2] THE NEUROPSYCHIATRY OF MULTIPLE-SCLEROSIS
    MENDEZ, MF
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 1995, 25 (02) : 123 - 135
  • [3] EPILEPSY IN MULTIPLE-SCLEROSIS
    GHEZZI, A
    MONTANINI, R
    BASSO, PF
    ZAFFARONI, M
    MASSIMO, E
    CAZZULLO, CL
    EUROPEAN NEUROLOGY, 1990, 30 (04) : 218 - 223
  • [4] INTERFERONS AND MULTIPLE-SCLEROSIS
    ARNASON, BGW
    REDER, AT
    CLINICAL NEUROPHARMACOLOGY, 1994, 17 (06) : 495 - 547
  • [5] INTERFERON IN MULTIPLE-SCLEROSIS
    不详
    CANADIAN JOURNAL OF STATISTICS-REVUE CANADIENNE DE STATISTIQUE, 1992, 20 (01): : 91 - 92
  • [6] IMMUNOLOGY OF MULTIPLE-SCLEROSIS
    WILLIAMS, KC
    ULVESTAD, E
    HICKEY, WF
    CLINICAL NEUROSCIENCE, 1994, 2 (3-4) : 229 - 245
  • [7] FRACTURES IN MULTIPLE-SCLEROSIS
    STENAGER, E
    JENSEN, K
    ACTA NEUROLOGICA BELGICA, 1991, 91 (05) : 296 - 302
  • [8] THERAPEUTICS OF MULTIPLE-SCLEROSIS
    NOSEWORTHY, JH
    CLINICAL NEUROPHARMACOLOGY, 1991, 14 (01) : 49 - 61
  • [9] CORTICOSTEROIDS AND MULTIPLE-SCLEROSIS
    DEFER, G
    CESARO, P
    DEGOS, JD
    ANNALES DE MEDECINE INTERNE, 1994, 145 : 37 - 41
  • [10] MULTIPLE-SCLEROSIS IN CHILE
    ALVAREZ, G
    CASTILLO, JL
    CARDENAS, M
    FAURE, E
    RUIZ, F
    LAVADOS, J
    ACTA NEUROLOGICA SCANDINAVICA, 1992, 85 (01): : 1 - 4